Differentiation of Recurrent Tumor and Posttreatment Changes in Head and Neck Squamous Cell Carcinoma: Application of High b-Value Diffusion-Weighted Imaging

REFERENCES

1. 1.↵
   1. El-Deiry M,
   2. Funk GF,
   3. Nalwa S,
   4. et al

   . Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer. Arch Otolaryngol Head Neck Surg 2005;131:879–85

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Ang KK,
   2. Harris J,
   3. Garden AS,
   4. et al

   . Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99–14. J Clin Oncol 2005;23:3008–15

   Abstract/FREE Full Text
3. 3.↵
   1. Zbaren P,
   2. Caversaccio M,
   3. Thoeny HC,
   4. et al

   . Radionecrosis or tumor recurrence after radiation of laryngeal and hypopharyngeal carcinomas. Otolaryngol Head Neck Surg 2006;135:838–43

   Abstract/FREE Full Text
4. 4.↵
   1. Nomayr A,
   2. Lell M,
   3. Sweeney R,
   4. et al

   . MRI appearance of radiation-induced changes of normal cervical tissues. Eur Radiol 2001;11:1807–17

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Offiah C,
   2. Hall E

   . Post-treatment imaging appearances in head and neck cancer patients. Clin Radiol 2011;66:13–24

   CrossRefPubMed
6. 6.↵
   1. Wang J,
   2. Takashima S,
   3. Takayama F,
   4. et al

   . Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 2001;220:621–30

   CrossRefPubMed
7. 7.↵
   1. Srinivasan A,
   2. Dvorak R,
   3. Perni K,
   4. et al

   . Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience. AJNR Am J Neuroradiol 2008;29:40–44

   Abstract/FREE Full Text
8. 8.↵
   1. Maeda M,
   2. Kato H,
   3. Sakuma H,
   4. et al

   . Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. AJNR Am J Neuroradiol 2005;26:1186–92

   Abstract/FREE Full Text
9. 9.↵
   1. Sumi M,
   2. Sakihama N,
   3. Sumi T,
   4. et al

   . Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol 2003;24:1627–34

   Abstract/FREE Full Text
10. 10.↵
    1. Vandecaveye V,
    2. De Keyzer F,
    3. Vander Poorten V,
    4. et al

    . Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009;251:134–46

    CrossRefPubMed
11. 11.↵
    1. Kim S,
    2. Loevner L,
    3. Quon H,
    4. et al

    . Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009;15:986–94

    Abstract/FREE Full Text
12. 12.↵
    1. King AD,
    2. Mo FK,
    3. Yu KH,
    4. et al

    . Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 2010;20:2213–20

    CrossRefPubMed
13. 13.↵
    1. Abdel Razek AA,
    2. Kandeel AY,
    3. Soliman N,
    4. et al

    . Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 2007;28:1146–52

    Abstract/FREE Full Text
14. 14.↵
    1. Vandecaveye V,
    2. De Keyzer F,
    3. Nuyts S,
    4. et al

    . Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 2007;67:960–71

    CrossRefPubMed
15. 15.↵
    1. Seo HS,
    2. Chang KH,
    3. Na DG,
    4. et al

    . High b-value diffusion (b = 3000 s/mm2) MR imaging in cerebral gliomas at 3T: visual and quantitative comparisons with b = 1000 s/mm2. AJNR Am J Neuroradiol 2008;29:458–63

    Abstract/FREE Full Text
16. 16.↵
    1. Kang Y,
    2. Choi SH,
    3. Kim YJ,
    4. et al

    . Gliomas: histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging–correlation with tumor grade. Radiology 2011;261:882–90

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Purroy F,
    2. Begue R,
    3. Quilez A,
    4. et al

    . Contribution of high-b-value diffusion-weighted imaging in determination of brain ischemia in transient ischemic attack patients. J Neuroimaging 2013;23:33–38

    CrossRefPubMed
18. 18.↵
    1. Choi SH,
    2. Paeng JC,
    3. Sohn CH,
    4. et al

    . Correlation of 18F-FDG uptake with apparent diffusion coefficient ratio measured on standard and high b value diffusion MRI in head and neck cancer. J Nucl Med 2011;52:1056–62

    Abstract/FREE Full Text
19. 19.↵
    1. Yun TJ,
    2. Kim JH,
    3. Kim KH,
    4. et al

    . Head and neck squamous cell carcinoma: Differentiation of histologic grade with standard- and high-b-value diffusion-weighted MRI. Head Neck 2013;35:626–31

    CrossRefPubMed
20. 20.↵
    1. Clark CA,
    2. Le Bihan D

    . Water diffusion compartmentation and anisotropy at high b values in the human brain. Magn Reson Med 2000;44:852–59

    CrossRefPubMedWeb of Science
21. 21.↵
    1. DeLano MC,
    2. Cooper TG,
    3. Siebert JE,
    4. et al

    . High-b-value diffusion-weighted MR imaging of adult brain: image contrast and apparent diffusion coefficient map features. AJNR Am J Neuroradiol 2000;21:1830–36

    Abstract/FREE Full Text
22. 22.↵
    1. Brugieres P,
    2. Thomas P,
    3. Maraval A,
    4. et al

    . Water diffusion compartmentation at high b values in ischemic human brain. AJNR Am J Neuroradiol 2004;25:692–98

    Abstract/FREE Full Text
23. 23.↵
    1. Maier SE,
    2. Bogner P,
    3. Bajzik G,
    4. et al

    . Normal brain and brain tumor: multicomponent apparent diffusion coefficient line scan imaging. Radiology 2001;219:842–49

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Sehy JV,
    2. Ackerman JJ,
    3. Neil JJ

    . Evidence that both fast and slow water ADC components arise from intracellular space. Magn Reson Med 2002;48:765–70

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Roth Y,
    2. Tichler T,
    3. Kostenich G,
    4. et al

    . High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology 2004;232:685–92

    CrossRefPubMed
26. 26.↵
    1. Ogura A,
    2. Hayakawa K,
    3. Miyati T,
    4. et al

    . Imaging parameter effects in apparent diffusion coefficient determination of magnetic resonance imaging. Eur J Radiol 2011;77:185–88

    CrossRefPubMed
27. 27.↵
    1. Thoeny HC,
    2. De Keyzer F,
    3. King AD

    . Diffusion-weighted MR imaging in the head and neck. Radiology 2012;263:19–32

    CrossRefPubMed
28. 28.↵
    1. Wheeler-Kingshott CA,
    2. Trip SA,
    3. Symms MR,
    4. et al

    . In vivo diffusion tensor imaging of the human optic nerve: pilot study in normal controls. Magn Reson Med 2006;56:446–51

    CrossRefPubMed
29. 29.↵
    1. Mehanna H,
    2. West CM,
    3. Nutting C,
    4. et al

    . Head and neck cancer–Part 2: Treatment and prognostic factors. BMJ 2010;341:c4690

    FREE Full Text
30. 30.↵
    1. Kubota K,
    2. Yokoyama J,
    3. Yamaguchi K,
    4. et al

    . FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004;31:590–95

    CrossRefPubMedWeb of Science